Olufemi I. Oluranti , Bernard O. Adele , Abayomi O. Ige , Elsie O. Adewoye
{"title":"Crotonaldehde oral exposure disrupt cardiac energy metabolism and induces oxidative stress via down-regulation of nrf-2 and up-regulation of PPARα","authors":"Olufemi I. Oluranti , Bernard O. Adele , Abayomi O. Ige , Elsie O. Adewoye","doi":"10.1016/j.etap.2025.104892","DOIUrl":null,"url":null,"abstract":"<div><div>Alterations in cardiac energy metabolic pathways have been linked to cardiac dysfunction. This study investigated cardiac energy metabolism in male rats exposed to crotonaldehyde. Thirty-six male Wistar rats (150–170 g; n = 9) were grouped into 4 (I-IV): Control (normal saline 10 mL/kg), crotonaldehyde (0.75, 1.5, and 2.5 mg/kg, p.o) for 28 days. Levels of creatinine-kinase-myocardial-band, cardiac-troponin-I, glucose increased significantly, while triglyceride, free-fatty-acid, and insulin reduced significantly in all groups compared with control. Cardiac Pyruvate level, hexokinase and pyruvate dehydrogenase activities increased significantly in all crotonaldehyde-treated groups compared with control. Cardiac levels of malondialdehyde and hydrogen-peroxide increased significantly, while glutathione and nuclear-factor-erythroid-2-related-factor-2 reduced; superoxide-dismutase and catalase activities decreased following crotonaldehyde exposure compared with control. Cardiac glucose-transporter-4 and peroxisome-proliferator-activated-receptor-alpha expression increased in groups III and IV, while carnitine-palmitoyltransferase1β expression decreased in group II but increased in groups III and IV compared with control. Crotonaldehyde exposure exerts cardio-toxic effects by altering cardiac energy metabolism.</div></div>","PeriodicalId":11775,"journal":{"name":"Environmental toxicology and pharmacology","volume":"121 ","pages":"Article 104892"},"PeriodicalIF":4.6000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Environmental toxicology and pharmacology","FirstCategoryId":"93","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1382668925002674","RegionNum":3,"RegionCategory":"环境科学与生态学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/12/4 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENVIRONMENTAL SCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Alterations in cardiac energy metabolic pathways have been linked to cardiac dysfunction. This study investigated cardiac energy metabolism in male rats exposed to crotonaldehyde. Thirty-six male Wistar rats (150–170 g; n = 9) were grouped into 4 (I-IV): Control (normal saline 10 mL/kg), crotonaldehyde (0.75, 1.5, and 2.5 mg/kg, p.o) for 28 days. Levels of creatinine-kinase-myocardial-band, cardiac-troponin-I, glucose increased significantly, while triglyceride, free-fatty-acid, and insulin reduced significantly in all groups compared with control. Cardiac Pyruvate level, hexokinase and pyruvate dehydrogenase activities increased significantly in all crotonaldehyde-treated groups compared with control. Cardiac levels of malondialdehyde and hydrogen-peroxide increased significantly, while glutathione and nuclear-factor-erythroid-2-related-factor-2 reduced; superoxide-dismutase and catalase activities decreased following crotonaldehyde exposure compared with control. Cardiac glucose-transporter-4 and peroxisome-proliferator-activated-receptor-alpha expression increased in groups III and IV, while carnitine-palmitoyltransferase1β expression decreased in group II but increased in groups III and IV compared with control. Crotonaldehyde exposure exerts cardio-toxic effects by altering cardiac energy metabolism.
期刊介绍:
Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.
Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals.
In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal.